Clinical evaluation of subjective and objective changes in motor activity and attention in children with attention-deficit/hyperactivity disorder in a double-blind methylphenidate trial

Journal of Child and Adolescent Psychopharmacology

Volumn 15, Issue 2, 2005, Pages 180-190

  Konrad, Kerstin ^a   Günther, Thomas ^a   Heinzel Gutenbrunner, Monika ^b   Herpertz Dahlmann, Beate ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ACTIMETRY; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BEHAVIOR; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPERACTIVITY; IMPULSIVENESS; MALE; MOTOR ACTIVITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROPSYCHOLOGICAL TEST; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TASK PERFORMANCE; TEACHER;

ANALYSIS OF VARIANCE; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COMPARATIVE STUDY; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; RESEARCH SUPPORT, NON-U.S. GOV'T;

EID: 19544375414     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2005.15.180     Document Type: Article

References (32)

1. American Academy of Child and Adolescent Psychiatry: Practice parameters for the use of stimulant medication in the treatment of children, adolescents, and adults with ADHD. J Am Acad Child Adolesc Psychiatry 41:26-49, 2002.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV) Washington (DC), American Psychiatric Association 1994.
3. Borcherding BG, Keysor CS, Cooper TB, Rapoport JL: Differential effects of methylphenidate and dextroamphetamine on the motor activity level of hyperactive children. Neuropsychopharmacology 2:255-263, 1989.
4. Brown H, Prescott R: Applied Mixed Models in Medicine. Chichester, John Wiley & Sons, Ltd., 1999.
5. Cohen J: Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale (New Jersey), Erlbaum, 1988.
6. Dane AV, Schachar RJ, Tannock R: Does actigraphy differentiate ADHD subtypes in a clinical research setting? J Am Acad Child Adolesc Psychiatry 39: 752-760, 2000.
7. de Sonneville LMJ: ANT 2.1 Amsterdam Neuropsychological Tasks, Manual. Amstelveen, Sonar, 2001.
8. de Sonneville LMJ, Njiokiktjien C, Bos H: Methylphenidate and information processing. Part I: Differentiation between responders and nonresponders. Part II: Efficacy in responders. J Clin Exp Neuropsychol 16:877-897, 1994.
9. Denney C, Rapport M: The cognitive pharmacology of stimulants in children with ADHD. In: Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. Edited by Solanto MV, Arnsten AFT, Castellanos FX. New York, Oxford University Press, 2001, pp 283-302.
10. Douglas VI: Cognitive control processes in attention-deficit/ hyperactivity disorder. In: Handbook of Disruptive Behavior Disorders. Edited by Quay HC, Hogan AE. New York, Kluwer Academic/Plenum, 1999, pp 105-138.
11. Döpfner M, Lehmkuhl G: Diagnostik-System für psychische Störungen im Kindes- und Jugendalter nach ICD-10 und DSM-IV. [Diagnostic System for Mental Disorders According to ICD-10 and DSM-IV in Children and Adolescents]. Bern, Huber, 1998.
12. Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S: Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 41:26-49, 2001.
13. Gualtieri CT, Hicks RE: Neuropharmacology of methylphenidate and a neural substrate for childhood hyperactivity. Psychiatr Clin North Am 8:875-892, 1985.
14. Herpertz SC, Wenning B, Mueller B, Qunaibi M, Sass H, Herpertz-Dahlmann B: Psychophysiological responses in ADHD boys with and without conduct disorder: Implications for adult antisocial behavior. J Am Acad Child Adolesc Psychiatry 40:1222-1230, 2001.
15. Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C: Executive function and attention-deficit/hyperactivity disorder: Stimulant medication and better executive function performance in children. Psychol Med 29:527-538, 1999.
16. Keppel G: Design and Analysis. Englewood Cliffs (New Jersey), Prentice Hall, 1991.
17. Konrad K, Gauggel S, Manz A, Scholl M: Inhibitory control in children with traumatic brain injury (TBI) and children with attention-deficit/ hyperactivity disorder (ADHD). Brain Inj 14:859-875, 2000a.
18. Konrad K, Gauggel S, Manz A, Scholl M: Lack of inhibition: A motivational deficit in children with attention-deficit/hyperactivity disorder and children with traumatic brain injury. Neuropsychol Dev Cogn Sect C Child Neuropsychol 6:286-296, 2000b.
19. Konrad K, Günther T, Hanisch C, Herpertz-Dahlmann B: Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 43:191-198, 2004.
20. Levy F, Swanson JM: Timing, space, and ADHD: The dopamine theory revisited. Aust N Z J Psychiatry 35:504-511, 2001.
21. Logan GD, Cowan WB: On the ability to inhibit thought and action: A theory of an act of control. Psychol Rev 91:295-327, 1984.
22. Logan GD, Schachar RF, Tannor R: Impulsivity and inhibitory control. Psychol Sci 8:60-64, 1997.
23. Porrino LJ, Rapoport JL, Behar D, Ismond DR, Bunney WE, Jr.: A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiatry 40:681-687, 1983a.
24. Porrino LJ, Rapoport JL, Behar D, Ismond DR, Bunney WE, Jr.: Related: A naturalistic assessment of the motor activity of hyperactive boys. II. Stimulant drug effects. Arch Gen Psychiatry 40:688-693, 1983b.
25. Rapport MD, Denney C: Titrating methylphenidate in children with attention-deficit/hyperactivity disorder: Is body mass predictive of clinical response? J Am Acad Child Adolesc Psychiatry 36: 523-530, 1997.
26. Solanto MV: Behavioral effects of low-dose methylphenidate in childhood attention-deficit disorder. Implications for a mechanism of stimulant drug action. J Am Acad Child Psychiatry 25:96-101, 1986.
27. Solanto MV, Abikoff H, Sonuga-Barke E, Schachar R, Logan GD, Wigal T, Hechtman L, Hinshaw S, Turkel E: The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: A supplement to the NIMH multimodal treatment study of AD/HD. J Abnorm Child Psychol 29:215-228, 2001.
28. Solanto MV: Dopamine dysfunction in AD/HD. Integrating clinical and basic neuroscience research. Behav Brain Res 10:65-71, 2002.
29. Swanson JM, Volkow ND: Pharmacokinetic and pharmacodynamic properties of stimulants: Implications for the design of new treatments for ADHD. Behav Brain Res 130:73-78, 2002a.
30. Swanson JM, Gupta S, Williams L, Agler D, Lerner M, Wigal: Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: Effects of activity level in the classroom and on the playground. J Am Acad Child Psychiatry 41: 1306-1314, 2002b.
31. Tannock R, Schachar R, Logan GD: Methylphenidate and cognitive flexibility: Dissociated dose effects in hyperactive children. J Abnorm Child Psychol 23:235-266, 1995.
32. Unnewehr S, Schneider S, Margraf J: Diagnostisches Interview bei Psychischen Störungen im Kindes- und Jugendalter. [Diagnostic Interview for Mental Disorders in Children and Adolescents]. Berlin, Springer, 1995.